A citation-based method for searching scientific literature

Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli, Gunes Gundem, Peter Van Loo, Inigo Martincorena, Peter Ganly, Laura Mudie, Stuart McLaren, Sarah O'Meara, Keiran Raine, David R Jones, Jon W Teague, Adam P Butler, Mel F Greaves, Arnold Ganser, Konstanze Döhner, Richard F Schlenk, Hartmut Döhner, Peter J Campbell. N Engl J Med 2016
Times Cited: 1591



R Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, Peter V Grauman, Sarah Shareef, Steven L Allen, Arnaud Pigneux, Meir Wetzler, Robert K Stuart, Harry P Erba, Lloyd E Damon, Bayard L Powell, Neal Lindeman, David P Steensma, Martha Wadleigh, Daniel J DeAngelo, Donna Neuberg, Richard M Stone, Benjamin L Ebert. Blood 2015
Times Cited: 384




List of shared articles



Times cited

Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia.
Joshua F Zeidner, Daniel J Lee, Mark Frattini, Gil D Fine, Judy Costas, Kathryn Kolibaba, Stephen P Anthony, David Bearss, B Douglas Smith. Clin Cancer Res 2021
1

Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia.
Daniel R Richardson, David M Swoboda, Dominic T Moore, Steven M Johnson, Onyee Chan, Jonathan Galeotti, Sonia Esparza, Mohammad O Hussaini, Hendrick Van Deventer, Matthew C Foster,[...]. Am J Hematol 2021
0

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
Matteo Molica, Carla Mazzone, Pasquale Niscola, Paolo de Fabritiis. Front Oncol 2021
2

Applications of next-generation sequencing in hematologic malignancies.
Lori A Ramkissoon, Nathan D Montgomery. Hum Immunol 2021
0


Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
Julia Stomper, Ruth Meier, Tobias Ma, Dietmar Pfeifer, Gabriele Ihorst, Nadja Blagitko-Dorfs, Gabriele Greve, Dennis Zimmer, Uwe Platzbecker, Anne Hagemeijer,[...]. Clin Epigenetics 2021
1

Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
Curtis A Lachowiez, Sanam Loghavi, Ken Furudate, Guillermo Montalban-Bravo, Abhishek Maiti, Tapan Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki,[...]. Blood Adv 2021
1

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Kongfei Li, Lieguang Chen, Hua Zhang, Lu Wang, Keya Sha, Xiaohong Du, Daiyang Li, Zhongzheng Zheng, Renzhi Pei, Ying Lu,[...]. Aging (Albany NY) 2021
0

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance.
Caixia Han, Xuefeng Gao, Yonghui Li, Juan Zhang, Erna Yang, Li Zhang, Li Yu. Front Oncol 2021
0

Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
Petra Kövy, Zoltán Őrfi, András Bors, András Kozma, László Gopcsa, János Dolgos, Nóra Lovas, József Harasztdombi, Viktor Lakatos, Ágnes Király,[...]. PLoS One 2021
0

Emerging roles of spliceosome in cancer and immunity.
Hui Yang, Bruce Beutler, Duanwu Zhang. Protein Cell 2021
0